Approved in 2010, Saxenda (liraglutide) was the first GLP-1 medication approved for weight loss in adults with obesity or overweight with at least one weight-related health issue
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer
Below is a detailed introduction to its potential uses based on current understanding: Growth Hormone Stimulation Mechanism of Action : Ipamrelin acts as a growth hormone secretagogue, stimulating the release of growth hormone (GH) from the anterior pituitary gland
Ghrelin and motilin receptors, along with the neuromedin U, neurotensin, and GPR38 receptors, form a cluster known as the ghrelin receptor family (Kojima and Kangawa, 2005)
It is also housed in a box that is well sealed with plastic
Most regions have that and then some